Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease

Clinical and Experimental Immunology

Volumn 157, Issue 3, 2009, Pages 395-399

  Messias Reason, I J ^a,b   Schafranski, M D ^b   Kremsner, P G ^a   Kun, J F J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Complement; FCN2 gene; L ficolin (ficolin 2); Lectin pathway; Rheumatic fever; Rheumatic heart disease

Indexed keywords

FICOLIN 1; FICOLIN 2; FICOLIN 3; GENE PRODUCT; LECTIN; LIPOTEICHOIC ACID; PATTERN RECOGNITION RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BINDING AFFINITY; CHILD; CONTROLLED STUDY; FCN2 GENE; FEMALE; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GRAM POSITIVE BACTERIUM; H FICOLIN GENE; HAPLOTYPE; HUMAN; INFECTION RISK; INNATE IMMUNITY; L FICOLIN GENE; M FICOLIN GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RECURRENCE RISK; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SCHOOL CHILD; STREPTOCOCCUS PYOGENES;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHRONIC DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LECTINS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; RISK; STREPTOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 67651222603     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.03975.x     Document Type: Article

References (24)

1. Carapetis JR, Currie BJ, Good MF. Towards understanding the pathogenesis of rheumatic fever. Scand J Rheumatol 1996 25 : 127 31.
2. Guidelines for the diagnosis of rheumatic fever. Jones Criteria 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA 1992 268 : 2069 73.
3. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005 366 : 155 68.
4. Guilherme L, Fae K, Oshiro SE, Kalil J. Molecular pathogenesis of rheumatic fever and rheumatic heart disease. Exp Rev Mol Med 2005 7 : 1 15.
5. Messias R, I, Schafranski MD, Jensenius JC, Steffensen R. The association between mannose-binding lectin gene polymorphism and rheumatic heart disease. Hum Immunol 2006 67 : 991 8.
6. Schafranski MD, Pereira FL, Scherner D, Torres R, Jensenius JC, Messias-Reason IJ. High-producing MBL2 genotypes increase the risk of acute and chronic carditis in patients with history of rheumatic fever. Mol Immunol 2008 45 : 3827 31.
7. Sallakci N, Akcurin G, Koksoy S et al. TNF-alpha G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF-alpha production. J Autoimmun 2005 25 : 150 4.
8. Runza VL, Schwaeble W, Mannel DN. Ficolins: novel pattern recognition molecules of the innate immune response. Immunobiology 2008 213 : 297 306.
9. Matsushita M, Fujita T. The role of ficolins in innate immunity. Immunobiology 2002 205 : 490 7.
10. Jensen ML, Honore C, Hummelshoj T, Hansen BE, Madsen HO, Garred P. Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Mol Immunol 2007 44 : 856 65.
11. Lynch NJ, Roscher S, Hartung T et al. L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J Immunol 2004 172 : 1198 202.
12. Aoyagi Y, Adderson EE, Rubens CE et al. L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway. Infect Immun 2008 76 : 179 88.
13. Munthe-Fog L, Hummelshoj T, Hansen BE et al. The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels. Scand J Immunol 2007 65 : 383 92.
14. Messias-Reason I, Kremsner PG, Kun JF. Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy. J Infect Dis 2009 199 : 801 4.
15. Cedzynski M, Nuytinck L, Atkinson AP et al. Extremes of L-ficolin concentration in children with recurrent infections are associated with single nucleotide polymorphisms in the FCN2 gene. Clin Exp Immunol 2007 150 : 99 104.
16. Hummelshoj T, Munthe-Fog L, Madsen HO, Fujita T, Matsushita M, Garred P. Polymorphisms in the FCN2 gene determine serum variation and function of Ficolin-2. Hum Mol Genet 2005 14 : 1651 8.
17. Ma YG, Cho MY, Zhao M et al. Human mannose-binding lectin and L-ficolin function as specific pattern recognition proteins in the lectin activation pathway of complement. J Biol Chem 2004 279 : 25307 12.
18. Atkinson AP, Cedzynski M, Szemraj J et al. L-ficolin in children with recurrent respiratory infections. Clin Exp Immunol 2004 138 : 517 20.
19. Krarup A, Thiel S, Hansen A, Fujita T, Jensenius JC. L-ficolin is a pattern recognition molecule specific for acetyl groups. J Biol Chem 2004 279 : 47513 19.
20. Gibofsky A, Kerwar S, Zabriskie JB. Rheumatic fever. The relationships between host, microbe, and genetics. Rheum Dis Clin North Am 1998 24 : 237 59.
21. Schafranski MD, Stier A, Nisihara R, Messias-Reason IJ. Significantly increased levels of mannose-binding lectin (MBL) in rheumatic heart disease: a beneficial role for MBL deficiency. Clin Exp Immunol 2004 138 : 521 5.
22. Schafranski MD, Pereira FL, Scherner D, Torres R, Messias-Reason IJ. Functional MASP2 gene polymorphism in patients with history of rheumatic fever. Hum Immunol 2008 69 : 41 4.
23. Takahashi K, Ip WE, Michelow IC, Ezekowitz RA. The mannose-binding lectin: a prototypic pattern recognition molecule. Curr Opin Immunol 2006 18 : 16 23.
24. Nayar S, Nayar PG, Cherian KM. Heart valve structure: a predisposing factor for rheumatic heart disease. Heart 2006 92 : 1151 2.